Clinical trials of the third Russian vaccine against coronavirus, which was created at the Scientific Center. Chumakov RAS, will be completed by December. Deputy Prime Minister of the Russian Federation Tatyana Golikova announced this at a meeting with members of the government.
According to her, studies of the whole virion inactivated vaccine began in Novosibirsk on October 6. All volunteers are doing well. On October 19, the second phase of the trial starts: 285 volunteers will be vaccinated.
It is noted that this vaccine uses either artificially weakened viruses that are not capable of causing disease, or already killed viruses (inactivated).
Recall that the first Sputnik V vaccine, developed by the Gamaleya Research Center for Electrochemistry with the support of the Russian Direct Investment Fund, was registered on August 11, and on September 9, the post-registration phase of its trials began in Russia. Today, President Vladimir Putin announced the registration of the second vaccine against COVID-19 in the Russian Federation. The drug was developed at the Novosibirsk center "Vector".